The following constitutes Amendment No. 8 to the Schedule 13D filed by the undersigned (“Amendment No. 8”). This Amendment No. 8 amends the Schedule 13D as specifically set forth herein.
Item 2. | Identity and Background. |
Item 2 is hereby amended to add the following:
In connection with the election of Martin Colombatto, Stephen Domenik and Eric Singer to the Board of Directors of the Issuer at the 2013 annual meeting of stockholders held on December 18, 2013 (the “2013 Annual Meeting”), as described in further detail in Item 4 below, Messrs. Colombatto and Domenik are no longer members of the Section 13(d) group and shall cease to be Reporting Persons immediately upon the filing of this Amendment No. 8. The remaining Reporting Persons will continue filing statements on Schedule 13D with respect to their beneficial ownership of securities of the Issuer to the extent required by applicable law. Each of the remaining Reporting Persons is party to the Joint Filing Agreement, as further described in Item 6.
Item 3. | Source and Amount of Funds or Other Consideration. |
Item 3 is hereby amended and restated as follow:
The aggregate purchase price of the 3,421,712 Shares owned directly by PCP II is approximately $16,016,279, including brokerage commissions. The Shares owned directly by PCP II were acquired with its working capital.
The aggregate purchase price of the 128,249 Shares owned directly by PCP III is approximately $550,921, including brokerage commissions. The Shares owned directly by PCP III were acquired with its working capital.
The aggregate purchase price of the 952,083 Shares owned directly by PCP I is approximately $4,049,843, including brokerage commissions. The Shares owned directly by PCP I were acquired with its working capital.
The aggregate purchase price for the 181,234 Shares owned directly by Mr. Singer is approximately $809,003, including brokerage commissions. Such Shares were acquired with Mr. Singer’s personal funds.
PCP II, PCP III and PCP I each effect purchases of securities primarily through margin accounts maintained for them with prime brokers, which may extend margin credit to them as and when required to open or carry positions in the margin accounts, subject to applicable federal margin regulations, stock exchange rules and the prime brokers’ credit policies. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the accounts.
Item 4. | Purpose of Transaction. |
Item 4 is hereby amended to add the following:
On December 20, 2013, the Issuer announced the final voting results from the 2013 Annual Meeting and the election of three of PCP II’s director nominees, Martin Colombatto, Stephen Domenik and Eric Singer, to the Board of Directors of the Issuer.
Item 5. | Interest in Securities of the Issuer. |
Item 5(a) - (c) is hereby amended and restated as follows:
(a) The aggregate percentage of Shares reported owned by each Reporting Person is based upon 45,716,953 Shares outstanding, which is the total number of Shares outstanding as of November 11, 2013 as reported in the Issuer’s Revised Preliminary Proxy Statement on Schedule 14A filed with the SEC on November 12, 2013.
As of the close of business on December 20, 2013, PCP II beneficially owns 3,421,712 Shares, constituting approximately 7.5% of the Shares outstanding. By virtue of their relationships with PCP II discussed in further detail in Item 2, each of Potomac Management II and Messrs. Solit and Singer may be deemed to beneficially own the Shares beneficially owned by PCP II.
As of the close of business on December 20, 2013, PCP III beneficially owns 128,249 Shares, constituting less than 1% of the Shares outstanding. By virtue of their relationships with PCP III discussed in further detail in Item 2, each of Potomac Management III and Messrs. Solit and Singer may be deemed to beneficially own the Shares beneficially owned by PCP III.
As of the close of business on December 20, 2013, PCP I beneficially owned 952,083 Shares, constituting approximately 2.1% of the Shares outstanding. By virtue of their relationships with PCP I discussed in further detail in Item 2, each of Potomac Management I and Mr. Solit may be deemed to beneficially own the Shares beneficially owned by PCP I.
As of the close of business on December 20, 2013, Mr. Singer directly owned 181,234 Shares, constituting less than 1% of the Shares outstanding.
As a result of certain of the matters described in Item 4 in the Schedule 13D, the Reporting Persons may be deemed to constitute a “group,” within the meaning of Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder by the SEC. The aggregate number of Shares that would be deemed beneficially owned collectively by the Reporting Persons as a group is 4,683,278, which represents approximately 10.2% of the Shares outstanding.
(b) PCP II, Potomac Management II and Messrs. Solit and Singer share the power to vote and dispose of the Shares beneficially owned by PCP II. PCP III, Potomac Management III and Messrs. Solit and Singer share the power to vote and dispose of the Shares beneficially owned by PCP III. PCP I, Potomac Management I and Mr. Solit share the power to vote and dispose of the Shares beneficially owned by PCP I. Mr. Singer has sole voting and dispositive power over the Shares he owns directly.
(c) Schedule A annexed hereto lists all transactions in the Shares by the Reporting Persons since the filing of Amendment No. 7. All of such transactions were effected in the open market, except as otherwise noted.
Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer. |
Item 6 is hereby amended to add the following:
On December 20, 2013, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons who will remain Reporting Persons subsequent to this Amendment No. 8 agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer to the extent required by applicable law. A copy of this agreement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 7. | Material to be Filed as Exhibits. |
Item 7 is hereby amended to add the following exhibit:
99.1 Joint Filing Agreement, dated December 20, 2013.
After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated: December 20, 2013 | POTOMAC CAPITAL PARTNERS II, L.P. |
| |
| By: | Potomac Capital Management II, L.L.C. |
| | General Partner |
| |
| By: | |
| Name: | Paul J. Solit |
| Title: | Co-Managing Member |
| POTOMAC CAPITAL MANAGEMENT II, L.L.C. |
| |
| By: | |
| Name: | Paul J. Solit |
| Title: | Co-Managing Member |
| POTOMAC CAPITAL PARTNERS III, L.P. |
| |
| By: | Potomac Capital Management III, L.L.C. |
| | General Partner |
| |
| By: | |
| Name: | Paul J. Solit |
| Title: | Co-Managing Member |
| POTOMAC CAPITAL MANAGEMENT III, L.L.C. |
| |
| By: | |
| Name: | Paul J. Solit |
| Title: | Co-Managing Member |
| POTOMAC CAPITAL PARTNERS L.P. |
| |
| By: | Potomac Capital Management, L.L.C. |
| | General Partner |
| |
| By: | |
| Name: | Paul J. Solit |
| Title: | Managing Member |
| POTOMAC CAPITAL MANAGEMENT, L.L.C. |
| |
| By: | |
| Name: | Paul J. Solit |
| Title: | Managing Member |
SCHEDULE A
Transactions in the Shares Since the Filing of Amendment No. 7 to the Schedule 13D
Shares of Common Stock Purchased | Price Per Share($) | Date of Purchase |
POTOMAC CAPITAL PARTNERS II, L.P.
1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.10 to $6.15, inclusive. The reporting person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, further information regarding the number of shares purchased at each separate price such shares were purchased.